Quantitative structure activity relationship and molecular simulations for the exploration of natural potent VEGFR-2 inhibitors: an in silico anti-angiogenic study

References

• Adams, D. H., Ju, C., Ramaiah, S. K., Uetrecht, J., & Jaeschke, H. (2010). Mechanisms of immune-mediated liver injury. Toxicological Sciences, 115(2), 307–321. doi:10.1093/toxsci/kfq009
   PubMed Web of Science ®Google Scholar
• Al‐Husein, B., Abdalla, M., Trepte, M., DeRemer, D. L., & Somanath, P. R. (2012). Antiangiogenic therapy for cancer: An update. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 32(12), 1095–1111. doi:10.1002/phar.1147
   Google Scholar
• Attia, S. M. (2010). Deleterious effects of reactive metabolites. Oxidative Medicine and Cellular Longevity, 3(4), 238–253. doi:10.4161/oxim.3.4.13246
   PubMed Web of Science ®Google Scholar
• Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. doi:10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Dai, Y., Hartandi, K., Ji, Z., Ahmed, A. A., Albert, D. H., Bauch, J. L., Bouska, J. J., Bousquet, P. F., Cunha, G. A., Glaser, K. B., Harris, C. M., Hickman, D., Guo, J., Li, J., Marcotte, P. A., Marsh, K. C., Moskey, M. D., Martin, R. L., Olson, A. M., … Michaelides, M. R. (2007). Discovery of N-(4-(3-Amino-1 H-indazol-4-yl) phenyl)-N ‘-(2-fluoro-5-methylphenyl) urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. Journal of Medicinal Chemistry, 50(7), 1584–1597.
   PubMed Web of Science ®Google Scholar
• Dai, Y., Hartandi, K., Soni, N. B., Pease, L. J., Reuter, D. R., Olson, A. M., Osterling, D. J., Doktor, S. Z., Albert, D. H., Bouska, J. J., Glaser, K. B., Marcotte, P. A., Stewart, K. D., Davidsen, S. K., & Michaelides, M. R. (2008). Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 18(1), 386–390. doi:10.1016/j.bmcl.2007.10.018
   PubMed Web of Science ®Google Scholar
• Dang, N. L., Hughes, T. B., Krishnamurthy, V., & Swamidass, S. J. (2016). A simple model predicts UGT-mediated metabolism. Bioinformatics, 32(20), 3183–3189. doi:10.1093/bioinformatics/btw350
   PubMed Web of Science ®Google Scholar
• DeZwaan, D. C., & Freeman, B. C. (2010). HSP90 manages the ends. Trends in Biochemical Sciences, 35(7), 384–391. doi:10.1016/j.tibs.2010.02.005
   PubMed Web of Science ®Google Scholar
• Dinges, J., Ashworth, K. L., Akritopolou-Zanze, I., Arnold, L. D., Baumeister, S. A., Bousquet, P. F., Cunha, G. A., Davidsen, S. K., Djuric, S. W., Gracias, V. J., Michaelides, M. R., Rafferty, P., Sowin, T. J., Stewart, K. D., Xia, Z., & Zhang, H. Q. (2006). 1, 4-Dihydroindeno [1, 2-c] pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters, 16(16), 4266–4271. doi:10.1016/j.bmcl.2006.05.066
   PubMed Web of Science ®Google Scholar
• Ferrara, N. (2002). VEGF and the quest for tumour angiogenesis factors. Nature Reviews Cancer, 2(10), 795–803. doi:10.1038/nrc909
   PubMed Web of Science ®Google Scholar
• Gelboin, H. V. (1980). Benzo [alpha] pyrene metabolism, activation and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes. Physiological Reviews, 60(4), 1107–1166. doi:10.1152/physrev.1980.60.4.1107
   PubMed Web of Science ®Google Scholar
• Gupta, C. L., Babu Khan, M., Ampasala, D. R., Akhtar, S., Dwivedi, U. N., & Bajpai, P. (2019). Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7. Journal of Biomolecular Structure and Dynamics, 37(18), 4721–4736.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Harmange, J.-C., Weiss, M. M., Germain, J., Polverino, A. J., Borg, G., Bready, J., Chen, D., Choquette, D., Coxon, A., DeMelfi, T., DiPietro, L., Doerr, N., Estrada, J., Flynn, J., Graceffa, R. F., Harriman, S. P., Kaufman, S., La, D. S., Long, A., … Zanon, R. (2008). Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: Design, synthesis, and evaluation. Journal of Medicinal Chemistry, 51(6), 1649–1667. doi:10.1021/jm701097z
   PubMed Web of Science ®Google Scholar
• Hughes, T. B., Miller, G. P., & Swamidass, S. J. (2015). Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Central Science, 1(4), 168–180. doi:10.1021/acscentsci.5b00131
   PubMed Web of Science ®Google Scholar
• Hughes, T. B., Miller, G. P., & Swamidass, S. J. (2015). Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. Chemical Research in Toxicology, 28(4), 797–809. doi:10.1021/acs.chemrestox.5b00017
   PubMed Web of Science ®Google Scholar
• Iqbal, J., Abbasi, B. A., Ahmad, R., Batool, R., Mahmood, T., Ali, B., Khalil, A. T., Kanwal, S., Afzal Shah, S., Alam, M. M., Bashir, S., Badshah, H., & Munir, A. (2019). Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives. Biomedicine & Pharmacotherapy, 109, 1381–1393. doi:10.1016/j.biopha.2018.10.107
   PubMed Web of Science ®Google Scholar
• Jana, S., & Singh, S. K. (2019). Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Journal of Biomolecular Structure and Dynamics, 37(4), 944–965.
   PubMed Web of Science ®Google Scholar
• Jia, J., Xu, Xli., Liu, F., Guo, Xke., Zhang, Mye., Lu, M., Xu, Lli., Wei, J., Zhu, J., Zhang, S., Zhang, S., Sun, H., & You, Q. (2013). Identification, design and bio-evaluation of novel Hsp90 inhibitors by ligand-based virtual screening. PloS One., 8(4), e59315. doi:10.1371/journal.pone.0059315
   PubMed Web of Science ®Google Scholar
• Joshi, T., Sharma, P., Joshi, T., & Chandra, S. (2019). In silico screening of anti-inflammatory compounds from Lichen by targeting cyclooxygenase-2. Journal of Biomolecular Structure and Dynamics, 1–19. doi:10.1080/07391102.2019.1664328
   Web of Science ®Google Scholar
• Kandakatla, N., & Ramakrishnan, G. (2014). Ligand based pharmacophore modeling and virtual screening studies to design novel HDAC2 inhibitors. Advances in Bioinformatics, 2014, 1–11. doi:10.1155/2014/812148
   Google Scholar
• Kovačević, S. Z., Jevrić, L. R., Kuzmanović, S. O. P., & Lončar, E. S. (2014). Prediction of in-silico ADME properties of 1, 2-o-isopropylidene aldohexose derivatives. Iranian Journal of Pharmaceutical Research : Ijpr, 13(3), 899–907.
   PubMed Web of Science ®Google Scholar
• Lahari, B. L., Rajkumar, T., Reddy, L. S. S., Reddy, Y. S. R., Sivudu, G., & Krishna, P. N. (2015). In-silico design, synthesis and biological evaluation of some Michael adducts from chalcones. Inventi Impact Med. Chem, 2015, 119–132.
   Google Scholar
• Lee, H., Saini, N., Howard, E. W., Parris, A. B., Ma, Z., Zhao, Q., Zhao, M., Liu, B., Edgerton, S. M., Thor, A. D., & Yang, X. (2018). Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells. Scientific Reports, 8(1), 6829. doi:10.1038/s41598-018-25284-0
   PubMed Web of Science ®Google Scholar
• Lian, L., Li, X.-L., Xu, M.-D., Li, X.-M., Wu, M.-Y., Zhang, Y., Tao, M., Li, W., Shen, X.-M., Zhou, C., & Jiang, M. (2019). VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer, 19(1), 183. doi:10.1186/s12885-019-5322-0
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. doi:10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lutz, W. K. (1979). In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutation Research/Reviews in Genetic Toxicology, 65(4), 289–356. doi:10.1016/0165-1110(79)90006-X
   Google Scholar
• Maj, E., Papiernik, D., & Wietrzyk, J. (2016). Antiangiogenic cancer treatment: The great discovery and greater complexity. International Journal of Oncology, 49(5), 1773–1784.
   PubMed Web of Science ®Google Scholar
• Nachiappan, M., Jain, V., Sharma, A., Manickam, Y., & Jeyakanthan, J. (2019). Conformational changes in glutaminyl-tRNA synthetases upon binding of the substrates and analogs using molecular docking and molecular dynamics approaches. Journal of Biomolecular Structure and Dynamics, 38, 1–1589. doi:10.1080/07391102.2019.1617787
   PubMed Web of Science ®Google Scholar
• Nebert, D. W., & Russell, D. W. (2002). Clinical importance of the cytochromes P450. The Lancet, 360(9340), 1155–1162. doi:10.1016/S0140-6736(02)11203-7
   PubMed Web of Science ®Google Scholar
• Paramashivam, S. K., Elayaperumal, K., Natarajan, B., Ramamoorthy, M., Balasubramanian, S., & Dhiraviam, K. (2015). In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation, 11(2), 73–84. doi:10.6026/97320630011073
   PubMed Web of Science ®Google Scholar
• Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011). Immune pathomechanism of drug hypersensitivity reactions. Journal of Allergy and Clinical Immunology, 127(3), S74–S81. doi:10.1016/j.jaci.2010.11.048
   PubMed Web of Science ®Google Scholar
• Qin, S., Li, A., Yi, M., Yu, S., Zhang, M., & Wu, K. (2019). Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. Journal of Hematology & Oncology, 12(1), 27. doi:10.1186/s13045-019-0718-5
   PubMed Web of Science ®Google Scholar
• Sak, K. (2012). Chemotherapy and dietary phytochemical agents.. Chemotherapy research and practice, 2012. doi:10.1155/2012/282570
   Google Scholar
• Schultz, T. W., Yarbrough, J. W., Hunter, R. S., & Aptula, A. O. (2007). Verification of the structural alerts for Michael acceptors. Chemical Research in Toxicology, 20(9), 1359–1363. doi:10.1021/tx700212u
   PubMed Web of Science ®Google Scholar
• Sharma, N., Sharma, M., Shakeel, E., Jamal, Q. M. S., Kamal, M. A., Sayeed, U., Khan, M. K. A., Siddiqui, M. H., Arif, J. M., & Akhtar, S. (2018). Molecular interaction and computational analytical studies of pinocembrin for its antiangiogenic potential targeting VEGFR-2: A persuader of metastasis. Medicinal Chemistry, 14(6), 626–640. doi:10.2174/1573406414666180416125121
   PubMed Web of Science ®Google Scholar
• Singh, S., Gupta, A. K., & Verma, A. (2013). Molecular Properties and Bioactivity score of the Aloe vera antioxidant compounds – in order to lead finding. Res. J. Pharm. Biol. Chem. Sci, 4(2), 876-881.
   Google Scholar
• Skariyachan, S., Manjunath, M., & Bachappanavar, N. (2019). Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii–insights from molecular docking, molecular dynamic simulations and in vitro assays. Journal of Biomolecular Structure and Dynamics, 37(5), 1146–1169. doi:10.1080/07391102.2018.1451387
   PubMed Web of Science ®Google Scholar
• Sławiński, J., Grzonek, A., Żołnowska, B., & Kawiak, A. (2015). Synthesis of novel Pyrido [4, 3-e][1, 2, 4] triazino [3, 2-c][1, 2, 4] thiadiazine 6, 6-dioxide derivatives with potential anticancer activity. Molecules, 21(1), 41.
   Web of Science ®Google Scholar
• Srivastava, A., Maggs, J. L., Antoine, D. J., Williams, D. P., Smith, D. A., & Park, B. K. (2010). Role of reactive metabolites in drug-induced hepatotoxicity. In Adverse drug reactions (pp. 165–194). Heidelberg, Berlin: Springer.
   Google Scholar
• Stachulski, A. V., Baillie, T. A., Kevin Park, B., Scott Obach, R., Dalvie, D. K., Williams, D. P., Srivastava, A., Regan, S. L., Antoine, D. J., Goldring, C. E. P., Chia, A. J. L., Kitteringham, N. R., Randle, L. E., Callan, H., Castrejon, J. L., Farrell, J., Naisbitt, D. J., & Lennard, M. S. (2013). The generation, detection, and effects of reactive drug metabolites. Medicinal Research Reviews, 33(5), 985–1080. doi:10.1002/med.21273
   PubMed Web of Science ®Google Scholar
• Testa, B., Pedretti, A., & Vistoli, G. (2012). Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discovery Today. , 17(11-12), 549–560. doi:10.1016/j.drudis.2012.01.017
   PubMed Web of Science ®Google Scholar
• ul Qamar, M. T., Maryam, A., Muneer, I., Xing, F., Ashfaq, U. A., Khan, F. A., & Siddiqi, A. R. (2019). Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Scientific reports, 9(1), 1433. doi:10.1038/s41598-018-38450-1
   Web of Science ®Google Scholar
• Xia, Y., Song, X., Li, D., Ye, T., Xu, Y., Lin, H., Meng, N., Li, G., Deng, S., Zhang, S., Liu, L., Zhu, Y., Zeng, J., Lei, Q., Pan, Y., Wei, Y., Zhao, Y., & Yu, L. (2015). YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models. Scientific Reports, 4(1), 6031. doi:10.1038/srep06031
   Web of Science ®Google Scholar